Sentinel surveillance of HIV and hepatitis C virus in two urban emergency departments

Canadian Journal of Emergency Medicine

Volumn 6, Issue 2, 2004, Pages 89-96

  Houston, Stan ^a   Rowe, Brian H ^a   Mashinter, Laura ^a   Preiksaitis, Jutta ^b   Joffe, Mark ^a   Mackey, Duncan ^a,c   Galbraith, John ^d   Wiebe, Natasha ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b PROVINCIAL LABORATORY FOR PUBLIC HEALTH   (Canada)

^c Lethbridge Regional Hospital   (Canada)

^d Dynacare Kasper Medical Laboratories   (Canada)

Author keywords

Emergency department; Hepatitis C; HIV; Seroprevalence; Surveillance

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BLOOD CELL COUNT; CONTROLLED STUDY; DISEASE ASSOCIATION; EMERGENCY HEALTH SERVICE; FEMALE; HEPATITIS C; HOSPITAL INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATIENT CARE; PATIENT INFORMATION; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PROSPECTIVE STUDY; RISK FACTOR; SEROPREVALENCE; STANDARD; URBAN AREA;

EID: 18244395041     PISSN: 14818035     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1481803500009040     Document Type: Article

References (20)

1. The report on the global HIV/AIDS epidemic: the Barcelona Report. The Joint United Nations Programme on HIV/AIDS. Geneva, Switzerland: 2002.
2. Centers for Disease Control and Prevention. Recommendations and reports. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Oct 16, 1998. MMWR Morbid Mortal Wkly Rep 1998;47(RR19):1-39. Available: www.cdc.gov/mmwr.preview/mmwrhtml/0005514.htm (accessed 2004 Jan 19).
3. Remis R. HIV incidence among injection drug users in Vancouver. CMAJ 2002;166:908-9.
4. Schabas R. Report on the meeting of the Expert Panel on Hepatitis C Epidemiology. Population and Public Health Branch (formerly LCDC). Ottawa: Health Canada; 1998.
5. Sturm JT. HIV prevalence in a midwestern emergency department. Ann Emerg Med 1991;20:276-8.
6. Goggin MA, Davidson AJ, Cantrill SV, O'Keefe LK, Douglas JM. The extent of undiagnosed HIV infection among emergency department patients: results of a blinded seroprevalence survey and a pilot HIV testing program. J Emerg Med 2000;19:13-9.
7. Kelen GD, Hexter DA, Hansen KN, Tang N, Pretorius S, Quinn TC. Trend in human immunodeficiency virus (HIV) infection among a patient population of an inner-city emergency department: implications for emergency department-based screening programs for HIV infection. Clin Infect Dis 1995;21:867-75.
8. Strathdee SA, Patrick DM, Currie SL, Cornelisse PG, Rekart ML, Montaner JS, et al. Needle exchange is not enough: lessons learned from the Vancouver injecting drug use study. AIDS 1997;11:F59-65.
9. Kelen GD, Shahan JB, Quinn TC. Emergency department-based HIV screening and counseling: experience with rapid and standard serologic testing. Ann Emerg Med 1999;33:147-55.
10. Evaluation of serum pooling for use in an anti-HCV seroprevalence study. 64th Conjoint Meeting on Infectious Diseases, Canadian Association of Clinical Microbiology and Infectious Diseases, Hamilton, Ont., 1996.
11. Schochetman G, George JR, editors. Detection of HIV infection using serologic techniques in AIDS testing. In: AIDS testing: a comprehensive guide to technical, medical, social, legal, and management issues. 2nd ed. New York: Springer-Verlag; 1994. p. 62-102.
12. Janssen RS, Satten GA, Stramer SL, Rawal BD, O'Brien TR, Weiblen BJ, et al. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA 1998;290:28-42.
13. Revised guidelines on ethical and legal considerations in anonymous unlinked HIV seroprevalence research. Federal Centre for AIDS Working Group on Anonymous Unlinked HIV Seroprevalence Research. CMAJ 1992;146(10):1743-6.
14. Global Programme on AIDS. Unlinked anonymous screening for the public health surveillance of HIV infections; proposed international guidelines. Geneva: World Health Organization; 1989.
15. Romanowski B, Campbell PJ, Preiksaitis JK, Fonseca K. Human immununodeficiency virus seroprevalence and risk behaviour in patients attending a sexually transmitted disease clinic in Alberta. Sex Transm Dis 1997;24:487-94.
16. Jacobs P, Calder P, Taylor M, Houston S, Saunders LD, Albert T. Cost effectiveness of Streetworks' needle exchange program of Edmonton. Can J Public Health 1999;90:168-71.
17. Remis R, in collaboration with the Hepatitis C Working Group for Blood-borne Pathogens Division, Laboratory Centre for Disease Control, Health Canada. Estimating the number of blood transfusion recipients infected by hepatitis C virus in Canada, 1960-85 and 1990-92. Ottawa: Health Canada; 1998. Available: www.hc-sc.gc.ca/pphb-dgspsp/hcai-iamss/bbp-pts/pdf/annex_e.pdf (accessed 2004 Jan 27).
18. Alter MJ, Kruszon-Moran MS, Nainan OV, McQuillan GM, Gao F, Moyer LA, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999;341:556-62.
19. Birse E, Shokoples S, Houston S. Demographic and clinical features of aboriginal and non-aboriginal patients with HIV infection in Northern Alberta. Can J Infect Dis 1999;10(suppl B):66B.
20. Wenstrom KD, Zuidema LJ. Determination of the seroprevalence of human immunodeficiency virus infection in gravidas by non-anonymous versus anonymous testing. Obstet Gynecol 1989;74:558-61.